ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Progyny Inc

Progyny Inc (PGNY)

25.425
-0.305
( -1.19% )
Updated: 13:55:38

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
25.425
Bid
25.43
Ask
25.44
Volume
463,184
25.18 Day's Range 25.805
23.90 52 Week Range 44.95
Market Cap
Previous Close
25.73
Open
25.64
Last Trade
3
@
25.4152
Last Trade Time
13:56:14
Financial Volume
$ 11,823,405
VWAP
25.5264
Average Volume (3m)
1,085,895
Shares Outstanding
96,499,402
Dividend Yield
-
PE Ratio
39.57
Earnings Per Share (EPS)
0.64
Revenue
1.09B
Net Profit
62.04M

About Progyny Inc

Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility sp... Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics. Show more

Sector
Misc Health & Allied Svc,nec
Industry
Misc Health & Allied Svc,nec
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Progyny Inc is listed in the Misc Health & Allied Svc sector of the NASDAQ with ticker PGNY. The last closing price for Progyny was $25.73. Over the last year, Progyny shares have traded in a share price range of $ 23.90 to $ 44.95.

Progyny currently has 96,499,402 shares outstanding. The market capitalization of Progyny is $2.45 billion. Progyny has a price to earnings ratio (PE ratio) of 39.57.

PGNY Latest News

New Survey from Progyny Shows Strong LGBTQ+ Demand for Inclusive Family Building Benefits

NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today released findings from its 2024...

Fertility Pioneer and Kindbody Founder Gina Bartasi Returns as CEO to Lead Company's Next Phase of Growth

Fertility Pioneer and Kindbody Founder Gina Bartasi Returns as CEO to Lead Company's Next Phase of Growth PR Newswire NEW YORK, June 11, 2024 Kindbody is the Largest Women-founded, Women-led...

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.145-7.7801958650727.5727.650525.18109681426.51149319CS
4-2.095-7.6126453488427.5228.8625.18103601527.03324059CS
12-12.485-32.933262991337.9138.9823.9108589529.57914861CS
26-11.545-31.228022721136.9742.0823.992451933.1685367CS
52-13.185-34.149184149238.6144.9523.982463834.19179266CS
156-39.345-60.745715609164.7768.3223.982861239.6085611CS
26010.40569.274300932115.0268.3214.990582484137.86873442CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GRDIGRIID Infrastructure Inc
$ 1.4384
(156.86%)
128.23M
ZAPPZapp Electric Vehicles Group Ltd
$ 3.07
(125.74%)
82.66M
MGOLMGO Global Inc
$ 0.7874
(71.77%)
150.87M
RELIReliance Global Group Inc
$ 0.6171
(57.79%)
117.12M
SMXSMX Security Matters Public Company
$ 0.1601
(34.54%)
164.41M
WHLRWheeler Real Estate Investment Trust Inc
$ 2.75
(-82.51%)
129.56k
KAVLKaival Brands Innovations Group Inc
$ 2.85
(-36.67%)
962.41k
SONNSonnet BioTherapeutics Holdings Inc
$ 1.01
(-33.99%)
303.2k
MBIOMustang Bio Inc
$ 0.5702
(-32.93%)
34.68M
TRVNTrevena Inc
$ 0.2399
(-32.31%)
36.94M
NVDANVIDIA Corporation
$ 130.99
(-3.39%)
363.22M
NKLANikola Corporation
$ 0.3513
(-26.95%)
192.99M
SMXSMX Security Matters Public Company
$ 0.1601
(34.54%)
164.4M
MGOLMGO Global Inc
$ 0.7874
(71.77%)
150.87M
GRDIGRIID Infrastructure Inc
$ 1.4384
(156.86%)
128.23M

PGNY Discussion

View Posts
JPetroInc JPetroInc 4 years ago
1 hell of a drop today - ugh!
👍️0
JPetroInc JPetroInc 4 years ago
$PGNY holding up well
👍️0
pauljack13 pauljack13 4 years ago
They were already mentioned on Investors Business Daily.
Starting to be known. Good growth small cap.
👍️0
JPetroInc JPetroInc 4 years ago
PGNY is an IPO that has flown under the financial awareness radar

I suspect they'll launch an 'awareness campaign' sometime after the 1st
👍️0
JPetroInc JPetroInc 4 years ago
non-stop buying spree today off the low of $23

this is going to $31 quickly

I suspect they will have a large awareness campaign soon

PGNY is expected to announce break even this FY20
👍️0
JPetroInc JPetroInc 4 years ago
IPO retracement finding support around $23 pps

👍️0
JPetroInc JPetroInc 5 years ago
Progyny, Inc. Announces Pricing of Initial Public Offering

Date : 10/25/2019 @ 12:01AM
Source : GlobeNewswire Inc.
Stock : Progyny Inc (PGNY)
Quote : 25.99 0.0 (0.00%)

Progyny (NASDAQ:PGNY)

https://ih.advfn.com/stock-market/NASDAQ/progyny-PGNY/stock-news/80991562/progyny-inc-announces-pricing-of-initial-public

Progyny, Inc., a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a price to the public of $13.00 per share. Progyny is offering 6,700,000 shares and the selling stockholders are offering 3,300,000 shares. In addition, certain selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the initial public offering price less the underwriting discount. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “PGNY” on October 25, 2019, and the offering is expected to close on October 29, 2019, subject to customary closing conditions.

J.P. Morgan, Goldman Sachs & Co. LLC and BofA Securities are acting as joint lead book-running managers for the offering. Citigroup is acting as book-running manager for the offering. Piper Jaffray, SVB Leerink and TPG Capital BD, LLC are acting as co-managers for the offering.

The offering is being made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from: J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attn: Prospectus Department, Telephone: 866-803-9204, Email: prospectus-eq_fi@jpmchase.com; Goldman Sachs & Co. LLC, 200 West Street, New York, New York 10282, Attn: Prospectus Department, Telephone: 866-471-2526, Facsimile: 212-902-9316, Email: prospectus-ny@ny.email.gs.com; and BofA Securities, One Bryant Park, New York, New York 10036, Attn: Prospectus Department, Email: dg.prospectus_requests@baml.com.

A registration statement relating to these securities has been filed with, and declared effective by, the U.S. Securities and Exchange Commission (SEC). Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Progyny

Progyny is a leading fertility benefits management company in the United States. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians. Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Contact

Progyny PR

Selena Yang
media@progyny.com

Progyny IR

James Hart
investors@progyny.com

👍️0

Your Recent History

Delayed Upgrade Clock